Tag: trial sponsor obligations

Clinical Trial Insurance and Compensation Rules in India

September 22, 2025

Clinical Trial Insurance and Compensation Rules in India Navigating India’s Clinical Trial Insurance and Participant Compensation Regulations Introduction India’s regulatory framework for clinical trials has evolved to prioritize participant protection, especially in matters of insurance coverage and compensation for trial-related injury or death. In response to growing public scrutiny and judicial interventions over the last…

Clinical Trials in India, Country-Specific Clinical Trials

Key Differences Between CTA and IND Submissions

August 17, 2025

digi

Key Differences Between CTA and IND Submissions CTA vs IND: Understanding the Key Differences in Clinical Trial Submissions Introduction: Why Compare CTA and IND? Clinical trial sponsors conducting studies across multiple regions often face the challenge of navigating distinct regulatory frameworks. In the United States, initiating a clinical trial requires filing an Investigational New Drug…

CTA (Clinical Trial Application), Regulatory Submissions and Approvals

Sponsor vs Investigator Responsibilities in ClinicalTrials.gov Registration

August 15, 2025

digi

Sponsor vs Investigator Responsibilities in ClinicalTrials.gov Registration Clarifying Sponsor vs Investigator Roles in ClinicalTrials.gov Registration Understanding the Regulatory Framework Registration of clinical trials on ClinicalTrials.gov is not just a formality—it’s a legal requirement under U.S. law (FDAAA 801 and 42 CFR Part 11) and an ethical obligation for research transparency. However, confusion often arises about…

Clinical Trial Registries and Result Disclosure, ClinicalTrials.gov Registration